Alnylam Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2011
Total Assets: $281.9M
Liabilities Breakdown FY2011
Total Liabilities: $163.9M
Asset Breakdown
Total Assets: $281.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $70.2M | 24.9% |
| Accounts Receivable | $1.5M | 0.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $14.6M | 5.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $275.0K | 0.1% |
| Other Assets | $195.3M | 69.3% |
Liabilities Breakdown
Total Liabilities: $163.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.8M | 3.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $158.1M | 96.5% |